Newsletter November 2022 No.212
Top News
On August 30, 2022, the "Pharmaceutical Manufacturers Association of Japan Press Conference" was held at Muromachi Mitsui Hall & Conference (Chuo-ku, Tokyo). Mr. Yasushi Okada, Chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ), made a presentation focusing on "the current situation and recognition of issues surrounding the pharmaceutical industry and the basic framework for solving these issues". The event was conducted in a hybrid format with both on-site and online participation, and was attended by 39 members of the press from 27 companies. The following is a summary of Chairman Okada's presentation and Q&A session.
Topics
Policy Research Institute page
Development and Approval Status of Drugs for Unmet Medical Needs -Trends in 2022
From JPMA
Necessity of Pharmaceutical Industry Policy as a National Strategy
Information
- Personnel Changes in the Pharmaceutical Manufacturers Association of Japan
- Major Activity Reports and Planned Activities
- 2023 Life Science Intellectual Property Forum: Current Status, Prospects and Challenges of Digital Therapeutics (DTx)
- Publication Introduction: "Tekisuto Bukku Seiyaku Sangyo 2022-2023